Detalhe da pesquisa
1.
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.
Int J Mol Sci
; 25(2)2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38255842
2.
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients.
Br J Haematol
; 202(5): 953-959, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37357817
3.
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Blood
; 137(25): 3507-3517, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651883
4.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632738
5.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Hematol Oncol
; 41(5): 877-883, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392141
6.
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.
Haematologica
; 107(4): 868-876, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092056
7.
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients.
Haematologica
; 107(3): 593-603, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691382
8.
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome.
Br J Haematol
; 192(6): 1068-1072, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32578873
9.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Blood
; 133(11): 1205-1216, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602617
10.
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
Hematol Oncol
; 39(3): 326-335, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739461
11.
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Haematologica
; 105(2): 448-456, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371416
12.
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Br J Cancer
; 121(2): 150-156, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209327
13.
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics.
Br J Haematol
; 181(2): 229-233, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611195
14.
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
J Transl Med
; 16(1): 172, 2018 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925389
15.
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
Blood
; 138(25): 2727-2730, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587233
16.
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.
Haematologica
; 103(7): 1209-1217, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674504
17.
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Hematol Oncol
; 41(3): 567-570, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190298
18.
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Am J Hematol
; 98(9): E237-E240, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382471
19.
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report.
Blood
; 136(6): 763-766, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32559271
20.
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.
Blood
; 126(16): 1921-4, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26276669